Health Care | Pharmaceuticals, Biotechnology & Life Sciences | Biotechnology
NASDAQ | Common Stock
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases.
Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase 1/2 clinical trials; and achromatopsia that is in Phase 1/2 clinical trials.
It is also developing an optogenetic product candidate to treat advanced retinal disease.
In addition, the company has initiated one preclinical program in otology; preclinical program in dry age-related macular degeneration; and two preclinical programs in targeting central nervous system disorders, including frontotemporal dementia and amyotrophic lateral sclerosis.
It has collaboration agreements with University of Florida; Bionic Sight, Inc.; and Otonomy, Inc. The company was incorporated in 1999 and is headquartered in Alachua, Florida.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Nov 21, 22 | -0.28 Increased by +30.00% | -0.28 |
| Sep 27, 22 | -0.36 Decreased by -28.57% | -0.34 Decreased by -5.88% |
| May 16, 22 | -0.33 Increased by +17.50% | -0.43 Increased by +23.26% |
| Feb 14, 22 | -0.45 Increased by +25.00% | -0.38 Decreased by -18.42% |
| Nov 9, 21 | -0.40 Increased by +33.33% | -0.35 Decreased by -14.29% |
| Sep 23, 21 | -0.28 Increased by +50.00% | -0.40 Increased by +30.00% |
| May 17, 21 | -0.40 Increased by +20.00% | -0.41 Increased by +2.44% |
| Feb 11, 21 | -0.60 Decreased by -27.66% | -0.59 Decreased by -1.69% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 22 | 0.00 Decreased by N/A% | -18.41 M Decreased by -7.54% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 22 | 325.00 K Decreased by -35.00% | -18.39 M Decreased by -51.50% | Decreased by -5.66 K% Decreased by -133.08% |
| Mar 31, 22 | 0.00 Decreased by N/A% | -14.29 M Increased by +3.75% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 21 | 0.00 Decreased by N/A% | -19.14 M Decreased by -23.81% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 21 | 0.00 Decreased by N/A% | -17.12 M Decreased by -11.31% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 21 | 500.00 K Decreased by -79.62% | -12.14 M Increased by +16.32% | Decreased by -2.43 K% Decreased by -310.53% |
| Mar 31, 21 | 0.00 Decreased by N/A% | -14.85 M Decreased by -32.73% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 20 | 0.00 Decreased by -100.00% | -15.46 M Decreased by -79.31% | Decreased by N/A% Decreased by N/A% |